ADPT
Adaptive Biotechnologies Corp

4,304
Mkt Cap
$2.41B
Volume
10.00
52W High
$20.76
52W Low
$6.26
PE Ratio
-39.55
ADPT Fundamentals
Price
$15.77
Prev Close
$16.47
Open
$17.82
50D MA
$17.21
Beta
1.78
Avg. Volume
1.96M
EPS (Annual)
-$0.3922
P/B
11.08
Rev/Employee
$447,457.19
Loading...
Loading...
News
all
press releases
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of Adaptive Biotechnologies from a "hold" rating to a "buy" rating in a report on Sunday...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CFO Sells 2,145 Shares of Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CFO Kyle Piskel sold 2,145 shares of the stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an...
MarketBeat·2d ago
News Placeholder
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $21.00
JPMorgan Chase & Co. boosted their price objective on Adaptive Biotechnologies from $20.00 to $21.00 and gave the company an "overweight" rating in a research report on Friday...
MarketBeat·3d ago
News Placeholder
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up on Better-Than-Expected Earnings
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up After Strong Earnings...
MarketBeat·3d ago
News Placeholder
Adaptive Biotechnologies Q4 Earnings Call Highlights
Adaptive Biotechnologies (NASDAQ:ADPT) executives said the company delivered remarkable performance in 2025, driven by sharp growth and improving profitability in its minimal residual disease (MRD...
MarketBeat·3d ago
News Placeholder
Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Adaptive Biotechnologies (ADPT) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·3d ago
News Placeholder
Adaptive Biotechnologies (NASDAQ:ADPT) Releases Quarterly Earnings Results, Beats Expectations By $0.10 EPS
Adaptive Biotechnologies (NASDAQ:ADPT - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.09) earnings per share for the quarter, topping the consensus...
MarketBeat·3d ago
News Placeholder
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Misses Revenue Estimates
Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of +52.63% and -0.44%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $2,304,963.12 in Stock
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 124,998 shares of the business's stock in a transaction dated Monday, February 2nd. The stock was sold at an...
MarketBeat·4d ago
News Placeholder
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Average Rating of "Moderate Buy" from Brokerages
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the ten ratings firms that are covering the firm, Marketbeat...
MarketBeat·5d ago
<
1
2
...
>

Latest ADPT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.